These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11316215

  • 1. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
    El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM.
    Am J Gastroenterol; 2001 Apr; 96(4):979-83. PubMed ID: 11316215
    [Abstract] [Full Text] [Related]

  • 2. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB, Szczesniak MM, Maclean JC, Brake HM, Cole IE, Cook IJ.
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [Abstract] [Full Text] [Related]

  • 3. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J, Fullerton H, Briseno M, Cui H, Fass R.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1123-30. PubMed ID: 15142202
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
    Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, Levine PA.
    Laryngoscope; 2001 Dec 15; 111(12):2147-51. PubMed ID: 11802014
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.
    Am J Gastroenterol; 1996 Sep 15; 91(9):1749-57. PubMed ID: 8792693
    [Abstract] [Full Text] [Related]

  • 6. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
    Wo JM, Grist WJ, Gussack G, Delgaudio JM, Waring JP.
    Am J Gastroenterol; 1997 Dec 15; 92(12):2160-5. PubMed ID: 9399745
    [Abstract] [Full Text] [Related]

  • 7. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.
    Am J Med; 2004 Jun 01; 116(11):740-8. PubMed ID: 15144910
    [Abstract] [Full Text] [Related]

  • 8. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
    Qua CS, Wong CH, Gopala K, Goh KL.
    Aliment Pharmacol Ther; 2007 Feb 01; 25(3):287-95. PubMed ID: 17269990
    [Abstract] [Full Text] [Related]

  • 9. Omeprazole as a diagnostic tool in gastroesophageal reflux disease.
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG.
    Am J Gastroenterol; 1997 Nov 01; 92(11):1997-2000. PubMed ID: 9362179
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.
    Am J Gastroenterol; 1996 Sep 01; 91(9):1758-65. PubMed ID: 8792694
    [Abstract] [Full Text] [Related]

  • 11. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
    Ours TM, Kavuru MS, Schilz RJ, Richter JE.
    Am J Gastroenterol; 1999 Nov 01; 94(11):3131-8. PubMed ID: 10566703
    [Abstract] [Full Text] [Related]

  • 12. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
    Ahmed TF, Khandwala F, Abelson TI, Hicks DM, Richter JE, Milstein C, Vaezi MF.
    Am J Gastroenterol; 2006 Mar 01; 101(3):470-8. PubMed ID: 16542282
    [Abstract] [Full Text] [Related]

  • 13. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
    Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S, Italian Lansoprazole Study Group.
    Am J Gastroenterol; 2002 Jun 01; 97(6):1357-64. PubMed ID: 12094850
    [Abstract] [Full Text] [Related]

  • 14. Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial.
    DiBaise JK, Olusola BF, Huerter JV, Quigley EM.
    Am J Gastroenterol; 2002 Apr 01; 97(4):843-50. PubMed ID: 12003417
    [Abstract] [Full Text] [Related]

  • 15. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 01; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 16. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M.
    J Pediatr; 2009 Apr 01; 154(4):514-520.e4. PubMed ID: 19054529
    [Abstract] [Full Text] [Related]

  • 17. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 01; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 18. Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients.
    Richter JE, Kahrilas PJ, Sontag SJ, Kovacs TO, Huang B, Pencyla JL.
    Am J Gastroenterol; 2001 Nov 01; 96(11):3089-98. PubMed ID: 11721754
    [Abstract] [Full Text] [Related]

  • 19. Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy.
    Condra LJ, Morreale AP, Stolley SN, Marcus D.
    Am J Manag Care; 1999 May 01; 5(5):631-8. PubMed ID: 10537869
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
    Ott EA, Mazzoleni LE, Edelweiss MI, Sander GB, Wortmann AC, Theil AL, Somm G, Cartell A, Rivero LF, Uchôa DM, Francesconi CF, Prolla JC.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1231-9. PubMed ID: 15882244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.